Business
Daiichi Sankyo : Receives Favorable Judgment in Damage Claim Filed by NTK
Daiichi Sankyo : Receives Favorable Judgment in Damage Claim Filed by

About this update from Daiichi Sankyo Company, Limited
Tokyo - (September 10, 2026) - As Daiichi Sankyo (TSE: 4568) has previously stated in the press releases dated November 22, 2023 and May 22, 2025, Northern TK Venture Pte. Ltd. (hereinafter, "NTK"), an indirect wholly-owned subsidiary of IHH Healthcare Berhad (hereinafter, "IHH"), filed a lawsuit before the Tokyo District Court against Daiichi Sankyo on October 16, 2023, seeking JPY 20 billion in damages and other relief (hereinafter, the "Lawsuit"). Subsequently, [...] This is an abstract of the document. To keep reading, click here and get access to the original version.
View stock analysis, news, and events for Daiichi Sankyo Company, Limited
More from Daiichi Sankyo Company, Limited
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients...
September 13, 2026
(Modification of Disclosed Matter) Notice Regarding Change in the Effective Date of the Absorption-type Merger of Daiichi Sankyo with Its...
August 28, 2026